VIAL-IL13xTSLP therapeutic
/ Vial
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 17, 2026
A Study to Test the Safety and Effects of VIAL-IL13xTSLP in Healthy Adults
(ANZCTR)
- P1 | N=24 | Recruiting | Sponsor: Vial Australia Pty Ltd
New P1 trial • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1